However, in genetic models such as FMR1-knockout (fragile X syndrome), in which mGluR5 signaling and synaptic protein synthesis are dysregulated, the effects of omega-3 treatment may be different or limited [129]. Here, GRM5 is linked to fragile X syndrome.